Apollo Hospitals Enterprise Limited has informed the Exchange regarding a press release dated August 12, 2025, titled "Apollo Hospitals announces Q1FY26 results".
APOLLOHOSP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Apollo Hospitals announced strong Q1FY26 results with consolidated revenue of Rs. 5,842 crore (up 15% YoY), EBITDA of Rs. 852 crore (up 26% YoY), and PAT of Rs. 433 crore (up 42% YoY). The Healthcare Services segment grew 11% to Rs. 2,935 crore with PAT of Rs. 384 crore. Apollo HealthCo (digital/pharmacy) revenue rose 19% to Rs. 2,472 crore, turning profitable at Rs. 57 crore PAT vs a loss last year. The board approved acquiring the remaining 50% stake in Apollo Gleneagles PET-CT (AGPCL) from Parkway Healthcare for Rs. 85 million, making it a wholly owned subsidiary. The company also granted 327,494 ESOP options at Rs. 5,258 per share and noted progress on the previously approved demerger of its omnichannel pharmacy and digital health business into Apollo Healthtech Limited, which has been filed with stock exchanges.
Strong quarterly performance with 42% PAT growth signals robust operational momentum. The AGPCL acquisition consolidates diagnostic services, while the ongoing demerger could unlock value by creating a focused listed entity for the digital/pharmacy business, potentially benefiting long-term shareholders.